Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide

被引:129
作者
Janbon, G
Himmelreich, U
Moyrand, F
Improvisi, L
Dromer, F
机构
[1] Inst Pasteur, Unite Mycol Mol, F-75724 Paris, France
[2] Univ Sydney, Inst Magnet Resonance Res, Dept Magnet Resonance Med, Sydney, NSW 2006, Australia
关键词
D O I
10.1046/j.1365-2958.2001.02651.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The capsule is certainly the most obvious virulence factor for Cryptococcus neoformans. The main capsule constituents are glucuronoxylomannans (GXM). Several studies have focused on the structure and chemistry of the GXM component of the capsule, yet little is known about the genetic basis of the capsule construction. Using a monoclonal antibody specific to a sugar epitope, we isolated a capsule-structure mutant strain and cloned by complementation a gene named CAS1 that codes for a putative membrane protein. Although no sequence homology was found with any known protein in the different databases, protein analysis using the PROPSEARCH software classified Cas1p as a putative glycosyltransferase. Cas1p is a well-conserved evolutionary protein, as we identified one orthologue in the human genome, one in the drosophila genome and four in the plant Arabidopsis thaliana genome. Analysis of the capsule structure after CASI deletion showed that it is required for GXM O-acetylation.
引用
收藏
页码:453 / 467
页数:15
相关论文
共 82 条
[1]   Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP [J].
Alspaugh, JA ;
Perfect, JR ;
Heitman, J .
GENES & DEVELOPMENT, 1997, 11 (23) :3206-3217
[2]   Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy [J].
Bacon, BE ;
Cherniak, R ;
KwonChung, KJ ;
Jacobson, ES .
CARBOHYDRATE RESEARCH, 1996, 283 :95-110
[3]  
BENNETT JE, 1965, J IMMUNOL, V94, P916
[4]   Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide [J].
Bhasin, N ;
Albus, A ;
Michon, F ;
Livolsi, PJ ;
Park, JS ;
Lee, JC .
MOLECULAR MICROBIOLOGY, 1998, 27 (01) :9-21
[5]  
BROCKENHAUSEN I, 1997, INTESTINAL CANC, P176
[6]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[7]   THE MOUSE ANTIBODY-RESPONSE TO INFECTION WITH CRYPTOCOCCUS-NEOFORMANS - VH AND VL USAGE IN POLYSACCHARIDE BINDING-ANTIBODIES [J].
CASADEVALL, A ;
SCHARFF, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :151-160
[8]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[9]   Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mono-nuclear cells [J].
Chaka, W ;
Verheul, AFM ;
Vaishnav, VV ;
Cherniak, R ;
Scharringa, J ;
Verhoef, J ;
Snippe, H ;
Hoepelman, IM .
INFECTION AND IMMUNITY, 1997, 65 (01) :272-278
[10]   Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans [J].
Chang, YC ;
Kwon-Chung, KJ .
JOURNAL OF BACTERIOLOGY, 1999, 181 (18) :5636-5643